GeneraMedix (Epoprostenol Formulation)

Business Data, Corporate Office and Headquarter Address

About

GeneraMedix (Epoprostenol Formulation) is Pharmaceuticals in Switzerland that focus on developer business. They cover business area such as developer, pulmonary arterial hypertension.

Business Type

Pharmaceuticals

Country

Switzerland

Founded

-

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

Gewerbestrasse 16
4123 Allschwil
Switzerland

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developerpulmonary arterial hypertension

* We use standard office opening hours in near GeneraMedix (Epoprostenol Formulation)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

GeneraMedix (Epoprostenol Formulation) Frequently Asked Questions

What or who is GeneraMedix (Epoprostenol Formulation)?

GeneraMedix (Epoprostenol Formulation) is Pharmaceuticals business from Switzerland that founded in - ( years old in ), GeneraMedix (Epoprostenol Formulation) business is focusing on Developer.

Where is GeneraMedix (Epoprostenol Formulation) headquarter and corporate office address?

GeneraMedix (Epoprostenol Formulation) headquarter office and corporate office address is located in Gewerbestrasse 16 4123 Allschwil Switzerland.

Where is GeneraMedix (Epoprostenol Formulation) country origins?

GeneraMedix (Epoprostenol Formulation) was founded in Switzerland.

What is Developer business focus on?

In , GeneraMedix (Epoprostenol Formulation) is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with GeneraMedix (Epoprostenol Formulation), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.